Caelyx 20 mg / 10 ml, 1 vial (Pegylated liposomal doxorubicin hydrochloride 2 mg/ml) by Baxter.
Indications: Metastatic breast cancer, advanced ovarian cancer, multiple myeloma (with bortezomib) and AIDS-related Kaposi's sarcoma.
Administration: Intravenous infusion, typically every 4 weeks per protocol.
Storage: Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Baxter / Janssen |
| Active ingredient | Pegylated liposomal doxorubicin hydrochloride 2 mg/ml (20 mg / 10 ml). |
| Strength & pack | 1 vial of 10 ml. |
| Form | Concentrate for solution for infusion |
| Storage | Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |